Considerable data demonstrate a high prevalence of depressive symptoms in cancer patients. This study introduces an experimental model to examine the effect of tumor on depressive-like behavior. Female C57BL/6 mice were injected i.p. with syngeneic ID8 ovarian carcinoma. Experiment 1 measured sucrose intake before and after tumor incubation to assess the effect of tumor on anhedonic depressive-like behavior. Experiment 2 examined effects of tumor and social housing on anhedonia and a second depressive-like behavior, tail suspension test (TST) immobility. Systemic proinflammatory and antiinflammatory cytokines were measured following each experiment. Additional behaviors assessed the specificity of tumor's effect on depressive-like behavior. Tumor caused a reduction in sucrose intake relative to baseline and control levels (P < .05). Moreover, individually-housed tumor-bearing mice exhibited a lower sucrose preference than group-housed tumor-bearing or control mice in either housing condition (P < .05). Although tumor-bearing mice exhibited less locomotion than controls (P < .001), there was no significant effect of tumor on TST immobility. Tumor caused higher levels of systemic proinflammatory and antiinflammatory cytokines and smaller body weight (P < .05), but appetite and motor capacity were not significantly affected. Statistical mediation analysis showed that circulating interleukin-6 partially mediated the effect between tumor and home cage locomotion (P < .01) but not between tumor and sucrose intake. It is concluded that tumor elicits anhedonic depressive-like behavior in a murine model of ovarian cancer. This may have important implications for etiology of depression in the clinical cancer setting.
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Introduction
Considerable data demonstrate a high prevalence of depressive symptoms in cancer patients (Raison and Miller, 2003) . The median prevalence for major depressive disorder (MDD) in cancer patients is estimated at 15%, while the median prevalence for all depressive disorders is 30% (Hotopf et al., 2002) . These rates are substantially higher than those found in the general population for MDD, which ranges from 2% to 4% (Kessler and Wang, 2009) .
Receiving a diagnosis of cancer may result in a cascade of responses such as shock, disbelief, anxiety, anger, and despair that could persist and develop into MDD (McDaniel et al., 1995) . Psychosocial factors in cancer patients that may increase the risk for developing MDD after receiving a cancer diagnosis include socioeconomic pressures, pessimistic personality traits, and social isolation (Weisman and Worden, 1976) . Social isolation, in particular, is a significant risk factor for MDD in the population at large. A series of studies in women showed that those who lacked a close confidante or had no outside employment were more likely than
